Wikidata

(Q39034547)

English

CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo.

scientific article published on January 2014

In more languages

Statements

title
CLM3, a multitarget tyrosine kinase inhibitor with antiangiogenic properties, is active against primary anaplastic thyroid cancer in vitro and in vivo (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
24423321
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24423321%20AND%20SRC:MED&resulttype=core&format=json
retrieved
5 March 2020
author
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39034547&oldid=1506756894"